ECSP045096A - Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1" - Google Patents

Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1"

Info

Publication number
ECSP045096A
ECSP045096A EC2004005096A ECSP045096A ECSP045096A EC SP045096 A ECSP045096 A EC SP045096A EC 2004005096 A EC2004005096 A EC 2004005096A EC SP045096 A ECSP045096 A EC SP045096A EC SP045096 A ECSP045096 A EC SP045096A
Authority
EC
Ecuador
Prior art keywords
heteroarilo
nociceptin
orl
derivatives
receiver
Prior art date
Application number
EC2004005096A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045096A publication Critical patent/ECSP045096A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Se describen novedosos compuestos de la fórmula en la cual R es heteroarilo optativamente sustituido ó R1 es H ó alquilo C1-C6 YR2 y R3 son -CH3, -OCH3 ó halo;ó una sal ó solvato farmacéuticamente aceptable de los mismos, composiciones farmacéuticas elaboradas con los mismos y el uso de dichos compuestos en el tratamiento del dolor, la ansiedad, la tos, el asma, la depresión y el alcoholismo.
EC2004005096A 2001-11-07 2004-05-06 Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1" ECSP045096A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33328401P 2001-11-07 2001-11-07

Publications (1)

Publication Number Publication Date
ECSP045096A true ECSP045096A (es) 2004-06-28

Family

ID=23302135

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005096A ECSP045096A (es) 2001-11-07 2004-05-06 Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1"

Country Status (27)

Country Link
US (1) US6727254B2 (es)
EP (1) EP1442036B1 (es)
JP (2) JP4246066B2 (es)
KR (1) KR100596261B1 (es)
CN (1) CN1252068C (es)
AR (1) AR037211A1 (es)
AT (1) ATE315566T1 (es)
BR (1) BR0213907A (es)
CA (1) CA2465871C (es)
CY (1) CY1105208T1 (es)
DE (1) DE60208724T2 (es)
DK (1) DK1442036T3 (es)
EC (1) ECSP045096A (es)
ES (1) ES2256590T3 (es)
HK (1) HK1063019A1 (es)
HU (1) HUP0402329A2 (es)
IL (2) IL161120A0 (es)
MX (1) MXPA04004276A (es)
MY (1) MY126268A (es)
NO (1) NO329026B1 (es)
NZ (1) NZ532088A (es)
PE (1) PE20030719A1 (es)
PL (1) PL370269A1 (es)
RU (1) RU2327698C2 (es)
TW (1) TWI317360B (es)
WO (1) WO2003039469A2 (es)
ZA (1) ZA200403404B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
US20040067950A1 (en) * 1998-07-27 2004-04-08 Schering-Plough Corporation High affinity ligands for nociceptin receptor ORL-1
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
ATE443699T1 (de) * 2002-12-06 2009-10-15 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
WO2005089761A1 (en) * 2004-03-17 2005-09-29 Pfizer Limited Combination for treating inflammatory diseases
EP1791838A2 (en) * 2004-09-15 2007-06-06 Schering-Plough Ltd. Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
PE20071159A1 (es) * 2005-10-31 2007-11-30 Schering Corp Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
WO2010010458A1 (en) * 2008-07-21 2010-01-28 Purdue Pharma L.P. Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
GB201115853D0 (en) 2011-09-14 2011-10-26 Proximagen Ltd New enzyme inhibitor compounds
US9724340B2 (en) * 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352707A (en) 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
TW590268U (en) * 2000-08-08 2004-06-01 Wistron Corp Heat dissipating device

Also Published As

Publication number Publication date
RU2004117542A (ru) 2006-01-10
PL370269A1 (en) 2005-05-16
TW200301765A (en) 2003-07-16
CA2465871A1 (en) 2003-05-15
CN1252068C (zh) 2006-04-19
DE60208724D1 (de) 2006-04-06
ATE315566T1 (de) 2006-02-15
NZ532088A (en) 2006-05-26
WO2003039469A3 (en) 2003-10-16
HK1063019A1 (en) 2004-12-10
ES2256590T3 (es) 2006-07-16
EP1442036A2 (en) 2004-08-04
US20030119847A1 (en) 2003-06-26
JP2005508367A (ja) 2005-03-31
MXPA04004276A (es) 2004-08-11
KR20050043725A (ko) 2005-05-11
CY1105208T1 (el) 2010-03-03
BR0213907A (pt) 2004-09-28
CN1582288A (zh) 2005-02-16
DE60208724T2 (de) 2006-11-02
JP4246066B2 (ja) 2009-04-02
KR100596261B1 (ko) 2006-06-30
TWI317360B (en) 2009-11-21
NO20042294L (no) 2004-07-15
HUP0402329A2 (hu) 2005-02-28
CA2465871C (en) 2009-01-20
IL161120A (en) 2010-11-30
MY126268A (en) 2006-09-29
AR037211A1 (es) 2004-10-27
DK1442036T3 (da) 2006-05-15
IL161120A0 (en) 2004-08-31
EP1442036B1 (en) 2006-01-11
RU2327698C2 (ru) 2008-06-27
US6727254B2 (en) 2004-04-27
NO329026B1 (no) 2010-08-02
WO2003039469A2 (en) 2003-05-15
JP2009035556A (ja) 2009-02-19
ZA200403404B (en) 2005-08-15
PE20030719A1 (es) 2003-08-28

Similar Documents

Publication Publication Date Title
CY1105208T1 (el) Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1
ME00555A (en) Tryasolyl tropane derivatives as ccr5 modulators
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
MY130803A (en) New quinuclidine amide derivatives
MY134017A (en) Mch antagonists and their use in the treatment of obesity
CO5080744A1 (es) Ligandos de alta afinidad para el receptor de nociceptina orl-1
AU2003242544A1 (en) New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
CY1111693T1 (el) Αντιιικοι παραγοντες
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
ATE302775T1 (de) Carbolinderivate
MX2009006018A (es) Derivados de quinuclidinol como antagonistas de receptores muscarinicos.
PL361361A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
IL174678A0 (en) Arylindenophyridines and arylindenophyrimidines and their use as adenosine a2a receptor antagonist
ATE346067T1 (de) Carbolinderivate
ATE386725T1 (de) Heterocyclylverbindungen
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
PL361282A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
PE20061037A1 (es) Compuestos tetraciclicos como moduladores de los receptores de glucocorticoides
SE0301371D0 (sv) New Compounds
BRPI0410237A (pt) metil indóis e metil pirrolopiridinas como agonistas adrenérgicos alfa-1
BR0112957A (pt) Composto, método de tratamento, uso de um composto, e, composição farmacêutica
AR010289A1 (es) Derivados de piperidina, procedimiento para su preparacion, formulaciones farmaceuticas que contienen los derivados y su uso en el tratamiento dedesordenes psicoticos
SE0403117D0 (sv) New compounds 1
GB0114699D0 (en) Organic compounds
TH62385A (th) อนุพันธ์ของเฮเทอโรแอริล ที่เป็นลิแกนด์ที่ดีกว่า สำหรับโนซิเซพทิน รีเซพเตอร์ orl-1